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Sarcoma botryoides, a variant of embryonal rhabdomyosarcoma,
is an extremely rare tumour and is usually diagnosed in childhood.
The Intergroup Rhabdomyosarcoma Study (IRS) reported that
rhabdomyosarcomas usually arise from the vagina in infancy and
in early childhood, whereas uterine rhabdomyosarcomas are more
often seen during adolescence (Hays et al, 1985).
The treatment of this tumour has changed dramatically over the
decades. In 1959, Daniel et al noted the frequent multicentric
origin of this tumour (Daniel et al, 1959). In the late 1960s some
authors (Rutledge and Sullivan, 1967) stated that pelvic exentera-
tion was the treatment of choice for this tumour; however, a
comprehensive review on the results of pelvic exenteration
showed that the results were unsatisfactory, particularly when the
tumour extended beyond the vagina (Hilgers, 1975).
During the 1970s combined treatment modalities including
chemotherapy and/or irradiation with limited surgery provided
better control of this disease and considerable improvement in
survival (Holton et al, 1973; Ghavimi et al, 1975; Ortega, 1979).
Cervical sarcoma botryoides has been associated with a more
favourable outcome than other genital rhabdomyosarcomas and a
more conservative approach has been advised under certain
circumstances (Montag et al, 1986; Brand et al, 1987; Daya and
Scully, 1988; Gordon and Montag, 1990; Lin et al, 1995).
This paper describes our recent experience with multiagent
chemotherapy and limited surgery in the treatment of early
cervical rhabdomyosarcoma in three young subjects.
CLINICAL HISTORIES
Case 1
A 22-year-old woman, gravida 0, presented in December 1994
complaining of genital bleeding. Her previous gynaecological
history was uneventful. On speculum examination a large cervical
polyp, measuring 4 3 4 3 3 cm, was seen and removed.
Microscopic examination revealed a botryoid sarcoma with more
than 30 mitoses per high-power field but, due to mechanical
distorsion of the polyp at removal, it was not possible to define
without doubts whether the margins were microscopically
involved by tumour (Figures 1 and 2).
Lymphangiography, intravenous pyelogram, magnetic reso-
nance of the pelvis and abdomen, transvaginal ultrasound,
colposcopy and hysteroscopy were all negative. Endometrial and
endocervical curettages and cervical biopsies in the area of the
excised tumour were negative. She was therefore classified as
stage IA according to the criteria of the IRS.
This patient received adjuvant chemotherapy with doxorubicin
25 mg m22 daily on days 1, 2 and 3 and ifosfamide 2 g m22 daily
on days 1, 2 and 3. Doxorubicin was given as bolus, whereas ifos-
famide was administered as a 24-h infusion. The treatment was
repeated every 3 weeks for three courses, without delay.
Myelotoxicity (WHO grade 3), alopecia (grade 3) and mucositis
(grade 1) were the most relevant side-effects.
Follow-up abdominal and transvaginal ultrasound, hysteroscopy
and colposcopy, revealed no evidence of residual disease. Random
biopsies of the cervix were all negative. Her first menstrual period
occurred 4 months after the end of the treatment. She was moni-
tored closely, with colposcopy, hysteroscopy and ultrasound every
3 months. Nine months later, colposcopy revealed a small cervical
polyp of approximately 1 cm in diameter. This was removed by
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Figure 1 Low-power photomicrograph shows a cervical polyp with spindle cells (H&E stain, magnification 25´)
Figure 2 High-power magnification shows spindle cells with mitoses (H&E stain; magnification 250´)diathermic loop. Microscopic examination revealed recurrence of
sarcoma botryoides with few mitoses. The margins were all nega-
tive and she was followed without further treatment. She continued
to show no evidence of local or distant recurrence 38 months after
the initial diagnosis.
Case 2
A 25-year-old, gravida 0, presented in February 1995 to a primary
care hospital, complaining of vaginal bleeding which had lasted
for 3 weeks. A cervical polyp was discovered and removed by
torsion. Histopathologic analysis was considered benign and the
patient did not receive additional therapy. In August 1995 she
noted again abnormal vaginal bleeding. On speculum examination
a cervical polyp was noticed and a polypectomy was again
performed.
Microscopic examination revealed a rhabdomyosarcoma with
few mitoses and she was referred to our department of gynaeco-
logical oncology. Review of the specimen removed in February
detected the presence of sarcoma botryoides. Magnetic resonance
imaging of the abdomen and the pelvis detected no metastatic
lesions. Colposcopy did not reveal any additional lesion but
hysteroscopy detected a small polyp arising from the inner third of
the cervical canal. The polyp was removed by means of endocer-
vical curettage and the microscopic examination confirmed the
persistence of sarcoma botryoides with involved margins. The
lesion was located too deeply in the endocervical canal to allow a
conization and no visible tumour remained after the curettage,
therefore we decided to treat the patient and to repeat the
hysteroscopy after each course of chemotherapy in order to detect
as soon as possible a local persistence. We decided to leave the
possibility of a cervicectomy or a hysterectomy only in case of
persistence under chemotherapy or in case of recurrence. She
received four courses of chemotherapy with the same regimen
described above. She experienced WHO grade 3 myelotoxicity,
grade 3 vomiting and grade 3 alopecia but did not require any
delay and completed the treatment by December 1995. Her first
menstrual period occurred in April 1996. She remained disease-
free 24 months following chemotherapy and 36 months following
initial diagnosis.
Case 3
A 20-year-old, gravida 0, underwent gynaecological examination
in March 1995, due to persistent irregular bleeding. Speculum
examination revealed a large polypoid lesion which extended
almost to the vaginal introitus. The polyp arose from the cervix by
a thin pedicle and was completely excised. Pathologic analysis
revealed sarcoma botryoides with more than 30 mitoses per high-
power field.
She was referred to our division of gynaecological oncology
where she underwent pelvic and abdominal computerized tomog-
raphy (CT) scan, hysteroscopy, colposcopy and transvaginal ultra-
sound without evidence of residual disease. Three courses of
chemotherapy, according to the regimen already described, were
administered without delay. The most relevant side-effects were
myelotoxicity grade 3, vomiting grade 2 and alopecia grade 3.
Normal menstrual periods were recorded during the treatment and
afterwards. She continued to show no evidence of local or distant
recurrence 38 months following the initial diagnosis.
DISCUSSION
The prognosis of patients with cervical sarcoma botryoides is
rather favourable when compared to other genital rhabdomyosar-
comas, particularly when the tumour arises in a single polypoid
lesion and when the polyp is completely removed or resected
(Perrone et al, 1990; Zeisler et al, 1998). The surgical aggressive-
ness for the management of this tumour has progressively
decreased from pelvic exenteration (often used until the 1970s) to
abdominal hysterectomy. Some authors have also proposed a more
conservative approach in recent years for cases with no macro-
scopic residual tumour after excision of the primary lesion
(Gordon and Montag, 1990; Lin et al, 1995).
Due to the lack of data on large populations about the outcome
of patients managed conservatively, we decided to treat these
patients with doxorubicin and ifosfamide after the excision of the
polyp. Therefore all three subjects received chemotherapy in
the absence of obvious residual tumour. Two of them had no
recurrence but the third subject had detection of residual tumour
9 months after the end of chemotherapy. In this case, repeat local
excision of the tumour was considered sufficient treatment
because no deep invasion of the cervical stroma was documented
and the patient remains disease-free.
This chemotherapy regimen was chosen because the combination
of doxorubicin and ifosfamide yielded fairly satisfactory results in
advanced or recurrent genital sarcomas in a previous multicentre
study (Leyvraz et al, 1995). Our results do not allow any definitive
conclusion about the effectiveness of this regimen in sterilizing
minimal amounts of residual tumour. The use of different regimens,
more prolonged administration or higher doses remains a matter of
discussion. Some authors (Hays et al, 1985) have noticed that
doxorubicin did not improve the outcome when added to pulse VAC
(vincristine, dactinomycin, cyclophosphamide) for patients with
macroscopic disease (Group III and IV). However, they also noticed
that doxorubicin was given at a relatively low-dose intensity.
Pelvic irradiation could be proposed as an alternative to adju-
vant chemotherapy. However, this treatment modality would inter-
fere with the ovarian function of these young subjects, making
conservative management meaningless. Although the follow-up is
still relatively short, all our patients maintain a normal menstrual
function. Their possible future fertility remains to be assessed.
The successful treatment of a shallow local recurrence with
simple resection raises the question whether close observation
without adjuvant treatment might be considered in those cases
where complete excision with ample uninvolved margin is docu-
mented. In 1988, Daya and Scully reported four subjects that
remained disease-free despite being treated by cervicectomy or
polypectomy, without any adjuvant treatment.
Irrespective of the chemotherapy chosen, our experience shows
that a conservative approach may be reasonable after complete
removal of a polypoid sarcoma botryoides arising from the cervix.
Updated follow-up techniques such as hysteroscopy, colposcopy
and transvaginal ultrasound may be useful for early detection of
recurrences and do not require admission to the hospital.
Hysterectomy may represent the definitive treatment in case of
recurrence but our first case shows that small polypoid recurrences
may still be managed successfully without hysterectomy.
The risk of metastatic spread remains a matter of some
concern;however, we did not find any report of metastatic disease
among the early cases treated conservatively in the last decade.
Some authors (Perrone et al, 1990) described a woman with local
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botryoides with deep infiltration into the cervical stroma. Since
one of our patients had local recurrence despite receiving
chemotherapy, the effectiveness of this chemotherapy regimen in
sterilizing distant micrometastases remains debatable.
In conclusion, conservative treatment of cervical polypoid
sarcoma botryoides is possible. The use of updated follow-up tech-
niques allows for early detection of persistent/recurrent tumour.
The use of adjuvant chemotherapy deserves further investigation.
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